These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 926781)

  • 1. Inhibition of prostatic 5alpha-reductase and 3alpha-hydroxysteroid dehydrogenase by two antiandrogens.
    Dupuy GM; Roberts KD; Bleau G; Chapdelaine A
    J Steroid Biochem; 1977 Nov; 8(11):1145-51. PubMed ID: 926781
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of 3 alpha-hydroxysteroid oxidoreductase and 5 alpha-reductase activity by antiandrogens and indomethacin in the rat prostate.
    Fukabori Y; Takezawa Y; Yamanaka H; Honma S
    Prostate; 1992; 21(4):255-67. PubMed ID: 1281319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution.
    Lin HK; Jez JM; Schlegel BP; Peehl DM; Pachter JA; Penning TM
    Mol Endocrinol; 1997 Dec; 11(13):1971-84. PubMed ID: 9415401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gossypol inhibits 5α-reductase 1 and 3α-hydroxysteroid dehydrogenase: Its possible use for the treatment of prostate cancer.
    Cao S; Wang G; Ge F; Li X; Zhu Q; Ge RS; Wang Y
    Fitoterapia; 2019 Mar; 133():102-108. PubMed ID: 30605780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-specific action of antiandrogens on androgen induced changes in hepatic microsomal 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase activity in the rat.
    Lax ER; Schriefers H
    Acta Endocrinol (Copenh); 1981 Oct; 98(2):261-6. PubMed ID: 6457494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
    Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
    Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The action of 5 alpha-dihydrotestosterone and antiandrogens on the activities of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase in the pituitary gland of gonadectomized rats.
    Ghraf R; Schneider K; Kirchhoff J; Hiemke C
    J Steroid Biochem; 1982 Apr; 16(4):545-52. PubMed ID: 6806544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
    Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
    Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease.
    Bauman DR; Steckelbroeck S; Williams MV; Peehl DM; Penning TM
    Mol Endocrinol; 2006 Feb; 20(2):444-58. PubMed ID: 16179381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5 Alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase activities in isolated canine prostatic epithelial cells.
    McKercher G; Chevalier S; Roberts KD; Bleau G; Chapdelaine A
    J Steroid Biochem; 1984 Nov; 21(5):549-54. PubMed ID: 6595475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase activities in ventral prostate epithelial and stromal cells from immature and mature rats.
    Orlowski J; Bird CE; Clark AF
    J Endocrinol; 1983 Oct; 99(1):131-9. PubMed ID: 6579162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
    J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate.
    Lin HK; Steckelbroeck S; Fung KM; Jones AN; Penning TM
    Steroids; 2004 Dec; 69(13-14):795-801. PubMed ID: 15582534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibition of testicular delta 5-3 beta-hydroxysteroid dehydrogenase and prostatic 5 alpha-reductase activities in rats and humans by strogen forte extract.
    Tóth I; Szécsi M; Julesz J; Faredin I; Behnke B
    Int Urol Nephrol; 1996; 28(3):337-48. PubMed ID: 8899474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate.
    Shibata Y; Ono Y; Kashiwagi B; Suzuki K; Fukabori Y; Honma S; Yamanaka H
    Urology; 2003 Nov; 62(5):942-6. PubMed ID: 14624931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibits luminal cell differentiation and androgen responsiveness of the ventral prostate without inhibiting prostatic 5alpha-dihydrotestosterone formation or testicular androgen production in rat offspring.
    Theobald HM; Roman BL; Lin TM; Ohtani S; Chen SW; Peterson RE
    Toxicol Sci; 2000 Dec; 58(2):324-38. PubMed ID: 11099645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).
    Penning TM; Burczynski ME; Jez JM; Lin HK; Ma H; Moore M; Ratnam K; Palackal N
    Mol Cell Endocrinol; 2001 Jan; 171(1-2):137-49. PubMed ID: 11165022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased ratio of 5 alpha-reductase: 3 alpha (beta)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate.
    Bruchovsky N; Lieskovsky G
    J Endocrinol; 1979 Mar; 80(3):289-301. PubMed ID: 86594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroidal antiandrogens and 5alpha-reductase inhibitors.
    Bratoeff E; Ramírez E; Murillo E; Flores G; Cabeza M
    Curr Med Chem; 1999 Dec; 6(12):1107-23. PubMed ID: 10519917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to prostatic 5 alpha-reductase inhibitors.
    Batzold FH
    Prog Clin Biol Res; 1981; 75B():269-82. PubMed ID: 6172801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.